Abbott Diagnostics Korea Inc. - Leading In Vitro Diagnostics Manufacturer in South Korea

📢 Company Overview:
   Abbott Diagnostics Korea Inc., founded on February 1, 1999, is a wholly-owned subsidiary of Abbott Laboratories (NYSE: ABT) specializing in in vitro diagnostics (IVD) manufacturing. Headquartered in Yongin, Gyeonggi-do, South Korea, the company employs approximately 784 people (2023) and serves as a critical manufacturing center for diagnostic reagents and Rapid test kits distributed to over 60 countries worldwide.

Company Profile (Updated April 2026)

Abbott Diagnostics Korea Inc. is a South Korean corporation operating in the medicinal and botanical manufacturing sector. As a key subsidiary of the global healthcare giant Abbott Laboratories, the company focuses on the research, development, production, and international sales of in vitro diagnostic (IVD) reagents and medical devices.

The company maintains active manufacturing operations at its facility in Giheung-gu, Yongin, producing immunochromatographic diagnostic kits and automated diagnostic systems that support clinical decision-making in hospitals, laboratories, and public health institutions globally.

Corporate History & Structure

- Founded: February 1, 1999 (Incorporation Date)

- Parent Company: Abbott Laboratories (NYSE: ABT) - Global healthcare company founded 1888, headquartered in Abbott Park, Illinois, USA

- Industry Sector: Medicinal and Botanical Manufacturing (NAICS/ISIC classification)

- Corporate Group: Part of Abbott's global network of 460+ affiliated companies worldwide

- Headquarters: 65 Borahagal-ro, Giheung-gu, Yongin-si, Gyeonggi-do, Korea 446-930

- Additional Manufacturing Site: 46, Hagal-ro 15beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, Korea 446-904

Headquarters & Contact Information

Primary Address:
   65 Borahagal-ro, Giheung-gu
   Yongin-si, Gyeonggi-do 446-930
   South Korea

Phone: +82 31 899 2800 / +82 2 3429 3500

Fax: +82 31 899 2825

Website: www.kr.abbott

Core Business Operations

In Vitro Diagnostics (IVD) Manufacturing

Abbott Diagnostics Korea specializes in the production of diagnostic reagents and rapid testing solutions including:

- Rapid Diagnostic Test Kits: Immunochromatographic kits for infectious disease detection including:    
• Influenza detection    
• Hepatitis B virus (HBV) screening    
• Dengue fever diagnosis    
• HIV 1/2 screening and confirmation tests    
• HCV (Hepatitis C) detection    
• Syphilis (HIV/SYP Duo) testing    
• RSV (Respiratory Syncytial Virus) detection

- Diagnostic Platforms: Automated diagnostic systems and analyzers that enhance laboratory testing efficiency and accuracy

- High-Performance Testing Systems: Equipment designed for high-throughput screening in clinical laboratories and public health programs

Global Supply Chain Activities (2025)

Recent customs records indicate active international trade operations:

- Exports: Immunochromatographic diagnostic kits to Pakistan (HCV, HBSAG, HIV/SYP Duo, HIV 1/2 3.0), Ecuador (RSV), and other global markets (June 2025)

- Imports: MDI (Molded Devices Inc.) filters and components from India for manufacturing processes (May-June 2025)

Financial Performance

Fiscal Year 2022 (Latest Available):

- Net Sales Revenue: Decreased by 6.55% year-over-year

- Total Assets: Decreased by 13.31% over the same period

- Operating Profit/Loss (EBIT): Decreased by 15.42%

- Net Profit Margin: Decreased by 1.68%

- Return on Equity (ROE): Decreased by 2.56%

- Employees: 784 (2023 data)

Regulatory Compliance & Quality

As a medical device manufacturer under the Abbott Laboratories umbrella, the company adheres to:

- ISO Certifications: International quality management standards for medical device manufacturing

- Global Regulatory Standards: Compliance with FDA (US), CE (Europe), and other international medical device regulations through parent company certification programs

- Good Manufacturing Practice (GMP): Adherence to pharmaceutical and diagnostic manufacturing quality standards

Strategic Positioning

Role in Abbott Global Network:

Abbott Diagnostics Korea serves as a strategic manufacturing hub within Abbott's global diagnostics division, contributing to the company's capability to supply diagnostic solutions to over 130 countries worldwide. The Korean facility supports Abbott's Core Laboratory, Rapid Diagnostics, and Point of Care business segments.

Key Competitive Advantages:

- Access to Abbott's global R&D infrastructure and 135+ years of healthcare innovation

- Manufacturing expertise in high-quality immunochromatographic diagnostic kits

- Strategic location in South Korea's Gyeonggi-do biotech/medical device cluster

- Integration with Abbott's global supply chain and distribution networks

Related Abbott Entities in South Korea

The Abbott group maintains multiple operations in South Korea:

- Abbott Rapid Diagnostics Co., Ltd.: 166 Jeongjail-ro, Bundang-gu, Seongnam-si, Gyeonggi-do (Focus: Rapid diagnostic distribution)

- Abbott Medical Korea Ltd.: 337 Eonju-ro, Gangnam-gu, Seoul (Focus: Medical devices and vascular products)

- Abbott Korea Ltd.: 421 Yeongdong-daero, Gangnam-gu, Seoul (Focus: Established pharmaceuticals and nutrition)

Research & Partnerships

Abbott Diagnostics Korea collaborates with international hospitals, research institutions, and public health organizations to advance precision medicine and public health initiatives. The company supports Abbott's global mission to develop diagnostic solutions for emerging infectious diseases and chronic conditions.

Contact Information Summary

Abbott Diagnostics Korea Inc.
   65 Borahagal-ro, Giheung-gu
   Yongin-si, Gyeonggi-do 446-930
   South Korea

Tel: +82 31 899 2800
   Fax: +82 31 899 2825
   Web: www.kr.abbott

Keywords: Abbott Diagnostics Korea, Abbott Laboratories, Yongin, Gyeonggi-do, South Korea, IVD manufacturer, diagnostic reagents, rapid test kits, HIV testing, HCV testing, immunochromatographic kits, medical device manufacturing, February 1999, 784 employees, infectious disease diagnostics, Core Laboratory, Abbott global network